Skip to main content

Life Sciences

21 CFR Part 11 Decoded: Signature/Record Linking

fda-signature-recording-linking

 

This is the final post in the 21 CFR Part 11 “mini-series” on Subpart B – Electronic Records. The last Section in Subpart B is 11.70 – Signature/Record Linking.

In the table below, the actual language from each regulation is on the left, and my personal interpretation of what that language means is on the right. Keep in mind that I do not represent the FDA and nothing in the “Interpretation” column should be taken as fact. 

11.70 – Signature/Record Linking

With that, we’ve made it through all of Subpart B – Electronic Records. Good work! With the next post, we’ll be moving into the home stretch by kicking off the mini-series on Subpart C – Electronic Signatures.

If you have questions between now and the next post, feel free to contact us. To read past posts in the 21 CFR Part 11 Decoded series, click here.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Marin Richeson

Marin joined the life sciences industry in 2001. Over the course of her tenure, she has held roles in clinical finance, IT, quality assurance, and validation. The diversity of her experience provides her with a unique perspective on the interconnectedness of this complex, multi-faceted industry. Marin Richeson is a lead business consultant in Perficient's life sciences practice.

More from this Author

Follow Us
TwitterLinkedinFacebookYoutubeInstagram